He succeeds Guido Sander, who has shifted to Singapore, to head high growth markets for Roche Diagnostics' Asia Pacific business.
Commenting on the development, Sander said: "His wide experience covering pharmaceuticals and diagnostics in countries which are at different stages of healthcare evolution will be valuable for the growth plans of the Roche Diagnostics India and neighbouring markets business."
"I look forward to being a part of this journey, where Roche Diagnostics' globally renowned solutions are made available in India, to bring patients and their loved ones health and peace of mind," Subramanyam said.